Skip to content

Supplier News

Sales exec at American Greetings moves up

American Greetings has promoted Bill DeWitt to senior vice president of the company’s North American Sales Group. The greeting card maker said Tuesday that DeWitt will lead a newly constituted sales division encompassing the United States, Canada and Mexico.

Pfizer wraps up King Pharmaceuticals acquisition

Pfizer Inc. has closed its $3.6 billion deal to acquire branded drug maker King Pharmaceuticals Inc. Pfizer said Tuesday that it has completed the acquisition through the merger of its Parker Tennessee Corp. subsidiary into King, which is now a wholly owned subsidiary of Pfizer.

Mylan approved for Neurontin generic

Mylan Inc. plans to ship generic gabapentin capsules, indicated for the treatment of a painful complication of shingles. The company said Monday that its Matrix Laboratories Ltd.

AmerisourceBergen becomes Humana’s Rx wholesaler

AmerisourceBergen Corp. has become the new pharmaceuticals distributor for Humana Pharmacy Solutions. Humana said Thursday that under the agreement, Valley Forge, Pa.-based AmerisourceBergen will be its primary wholesaler for drug purchasing. The five-year pact goes into effect on May 1.

Bayer Consumer Care names president

Former Pfizer executive Erica Mann is set to join Bayer HealthCare LLC as the new president of its Consumer Care Division. Plans call for Mann, most recently president and general manager of Pfizer Nutritional Health, to start at Bayer on March 14.

American Greetings gives online peek at what’s new in stores

American Greetings Corp. has enabled consumers to shop for electronic greeting cards on its web site for quite some time, and now they also can go online to find out what’s new in the card aisle at stores. The greeting card company said this week it has launched a new page on AmericanGreetings.com

Forest Labs to acquire Clinical Data

Forest Laboratories Inc. plans to buy specialty pharmaceutical firm Clinical Data Inc. in a deal valued at $1.2 billion. The companies said Tuesday that under the agreement, Forest will acquire Clinical Data for $30 per share in cash plus up to $6 per share upon achievement of certain commercial